Infection epidemiology in relation to different therapy phases in patients with haematological malignancies receiving CAR T-cell therapy.
Nicol Garcia-PoutonValentín Ortiz-MaldonadoOlivier PeyronyMariana ChumbitaTommaso Francesco AielloPatricia Monzo-GalloCarlos LoperaPedro Puerta-AlcaldeLaura MagnanoNuria Martinez-CibrianCristina PitartManel JuanJulio DelgadoCarlos Fernandez De LarreaAlex SorianoÁlvaro Urbano-IspizuaCarolina García-VidalPublished in: European journal of haematology (2023)
Infections after CAR T-cell therapy were frequent. During the neutropenic phase, it is essential to prevent nosocomial infections and balance the use of antibiotics to lower endogenous bacteraemia and Clostridial infection rates.